Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

Jumbo phages utilize a complex protein import system, with Imp1 as a key gatekeeper, to transport proteins into their ...

A team from the University of Washington led by Nobel laureate David Baker is using artificial intelligence to design ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Unfortunately, there isn't an enzyme for many reactions we would sorely like to catalyze—things like digesting plastics or ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

Enzymes significantly speed up the chemical reactions that keep you alive. Researchers are using AI to create new ones to tackle modern challenges.

Covalent bonding is a widely understood phenomenon that joins the atoms of a molecule by a shared electron pair. But in ...

Hugh O'Neill conducts plant cell wall research as part of the DOE Solvent Disruption of Biomass and Biomembranes Science ...